“You know, that is a 100 million sensor facility. We are probably gonna be bumping up against capacity at that facility probably in the next couple of years.”

In context

“ions, You know, those are gonna happen also. I just cannot call it to the exact quarter. So these reimbursement opportunities, they are going to accelerate it And until that happens, I guess I would say, yeah, you are at this you are at this like, 8, 9% growth rate, which on a $2 billion or, you know, approaching $10 billion business, that is not a bad business to be in. And I would say we feel so strongly about this market and the ability for this market to accelerate and to grow and the potential that exists that, you know, we are probably in the final stages here of, planning for a fifth manufacturing facility. You know, we got our facility up, our last facility, our fourth facility. We got up and running probably in the 2024 time frame, given the trajectory that I am seeing right now. You know, that is a 100 million sensor facility. We are probably gonna be bumping up against capacity at that facility probably in the next couple of years. So we are already looking at our fifth facility at it will probably be a billion dollar investment that, you know, we are right now, we are looking at where we are make that investment, whether it is going to be in the United States or internationally. If it is going to be in the United States, what state we are gonna do. So we feel good about this market, Larry. And we have got plenty of growth drivers here. I would just go back to--you have got 80 million people that can use this product, and clinical data suggests that they should be using the product, and the health care systems will benefit when they do use the product. And currently, we are at 15. So I feel very good about feel very good about our business and about our position. Regarding I think you had a question about, well, you”